MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 63 filers reported holding MEI PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $244 | -99.9% | 1,000,000 | 0.0% | 0.01% | -17.6% |
| Q3 2022 | $387,000 | -36.0% | 1,000,000 | 0.0% | 0.02% | -46.9% |
| Q2 2022 | $605,000 | +0.3% | 1,000,000 | 0.0% | 0.03% | +28.0% |
| Q1 2022 | $603,000 | -77.4% | 1,000,000 | 0.0% | 0.02% | -65.3% |
| Q4 2021 | $2,670,000 | -3.3% | 1,000,000 | 0.0% | 0.07% | +16.1% |
| Q3 2021 | $2,760,000 | -3.2% | 1,000,000 | 0.0% | 0.06% | +6.9% |
| Q2 2021 | $2,850,000 | +9.3% | 1,000,000 | +31.6% | 0.06% | +26.1% |
| Q1 2021 | $2,607,000 | +30.0% | 760,000 | 0.0% | 0.05% | +7.0% |
| Q4 2020 | $2,006,000 | -15.4% | 760,000 | 0.0% | 0.04% | -25.9% |
| Q3 2020 | $2,371,000 | -19.6% | 760,000 | +6.4% | 0.06% | -30.1% |
| Q2 2020 | $2,949,000 | – | 714,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |